Related Experiment Video
Updated: Jan 7, 2026

08:15
Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
Published on: January 31, 2020
9.0K
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Xin Xia1, Haitang Li2, Sangeetha Satheesan3
1Department of Molecular and Cellular Biology, Beckman Research Institute of City of Hope; xixia@coh.org.
Journal of Visualized Experiments : Jove
|January 22, 2019
Summary
Researchers developed a humanized NOD/SCID/IL2rγnull (NSG) mouse model (hu-NSG) for studying human diseases. This model successfully recapitulates human immune system development and HIV-1 infection responses.
Area of Science:
- Immunology
- Pathology
- Transplantation Biology
Background:
- Small animal models are crucial for human disease research due to ethical and technical constraints.
- Mice, particularly the NOD/SCID/IL2rγnull (NSG) strain, offer genetic and behavioral similarities to humans, making them valuable for disease modeling.
- The NSG mouse allows for the engraftment of human hematopoietic stem cells, enabling the development of a functional human immune system.
Purpose of the Study:
- To establish a detailed protocol for generating a humanized NSG mouse model (hu-NSG).
- To demonstrate the utility of the hu-NSG model for studying human-specific diseases, such as HIV/AIDS.
- To assess the model's ability to recapitulate human immune responses and therapeutic interventions.
Main Methods:
- Hematopoietic stem cell transplantation into radiation-conditioned neonatal NSG mice.
- Generation of the humanized NSG (hu-NSG) mouse model.
- Evaluation of multi-lineage development of human stem cells and HIV-1 infection susceptibility.
Main Results:
- Successful generation of the hu-NSG mouse model.
- Demonstrated multi-lineage development of transplanted human hematopoietic stem cells within the NSG microenvironment.
- Confirmed susceptibility of the hu-NSG model to HIV-1 infection.
- The model recapitulated key biological characteristics in response to combinatorial antiretroviral therapy (cART).
Conclusions:
- The hu-NSG mouse model provides a robust platform for studying human immunology and infectious diseases.
- This model is valuable for understanding disease prognosis, pathophysiology, and evaluating therapeutic strategies for human-specific conditions like HIV/AIDS.
- The hu-NSG model effectively mimics human responses to antiretroviral therapy, aiding in drug development and cure research.

